Document is current
Any future updates will be listed below
-
Authors
Dignass, Axel https://orcid.org/0000-0002-9724-054X
Ainsworth, Claire
Hartz, Susanne https://orcid.org/0000-0001-8475-0260
Dunnewind, Niels
Redondo, Isabel
Sapin, Christophe
Kroep, Sonja
Halfpenny, Nicholas
Arcà, Emanuele
Hoque, Sami
-
Funding
Funding for this research was provided by:
The preparation of the manuscript was funded by Eli Lilly and Company.
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 16 September 2024
First Online: 15 October 2024
Declarations
:
: Axel Dignass reports no conflicts of interest for the work under consideration for publication. Claire Ainsworth, Niels Dunnewind, Sonja Kroep, Nicholas Halfpenny and Emanuele Arcà are employees of OPEN Health at the time of this study and its analysis. OPEN Health received funding from Eli Lilly and Company for the design and conduct of this study, statistical analysis and study report preparation. Susanne Hartz, Isabel Redondo and Christophe Sapin are employees and minor shareholders of Eli Lilly and Company. Sami Hoque has no competing interests to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
